FDA hands In­di­a's Nat­co Phar­ma an­oth­er 483, with eight ob­ser­va­tions cit­ed 

In­di­an man­u­fac­tur­er Nat­co Phar­ma has been hit with an­oth­er 483, fol­low­ing an FDA in­spec­tion made at its phar­ma man­u­fac­tur­ing fa­cil­i­ty, lo­cat­ed at 509 228 Telan­gana …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER